BlackRock, Inc. filed a Schedule 13G with the SEC on October 27, 2026, reporting beneficial ownership of 3,667,682 shares of Omada Health common stock, representing 6.0% of the class, based on a triggering event dated September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: BlackRock reported beneficial ownership of 3,667,682 shares of Omada Health common stock.
  • Percent of class: The reported stake represents 6.0% of Omada Health's outstanding common shares.
  • Sole voting power: BlackRock reported sole power to vote or direct the vote of 3,586,364 shares, with 0 shares subject to shared voting power.
  • Sole dispositive power: BlackRock reported sole power to dispose or direct the disposition of 3,667,682 shares, with 0 shares subject to shared dispositive power.
  • Filing basis: BlackRock identified itself as a parent holding company or control person under Rule 13d-1(b)(1)(ii)(G), incorporated in Delaware.
  • No single person's interest exceeds 5%: According to the filing, "No one person's interest in the common stock of OMADA HEALTH is more than five percent of the total outstanding common shares."

BlackRock's Schedule 13G Filing on Omada Health Common Stock

BlackRock, Inc., headquartered at 50 Hudson Yards, New York, NY 10001, filed a Schedule 13G disclosing a position in Omada Health (CUSIP: 68170A108), whose principal executive offices are located at 611 Gateway Blvd, Suite 120, South San Francisco, CA 94080. The event triggering the filing occurred on September 30, 2026, and the statement was signed by Spencer Fleming, Managing Director, on October 27, 2026.

According to the filing, the Schedule 13G "reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the 'Reporting Business Units') of BlackRock, Inc. and its subsidiaries and affiliates." The filing adds that it "does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units" in accordance with SEC Release No. 34-39538 (January 12, 1998). The relevant subsidiary information is identified in Exhibit 99 attached to the filing.

The filing certifies that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." Various persons are noted to have the right to receive dividends or proceeds from the sale of the common stock, though no individual person's interest exceeds five percent of total outstanding shares, according to the disclosure.

What Was Disclosed

BlackRock, Inc. reported beneficial ownership of 3,667,682 shares of Omada Health common stock, equal to 6.0% of the class, with sole voting power over 3,586,364 shares and sole dispositive power over 3,667,682 shares, as of September 30, 2026.